KIAA1244 activators represent a specific category of chemical compounds that are designed to target and modulate the activity of the KIAA1244 gene. The KIAA1244 gene is part of a unique class of genes that have been identified and cataloged for their distinct roles in cellular biology, yet many aspects of their functions remain to be fully understood. Activators targeting KIAA1244 are of particular interest in molecular biology and genetics due to their ability to influence the expression and functional dynamics of this gene. The interaction between these activators and the KIAA1244 gene involves a complex mechanism, where the activators bind to specific sites or interact with regulatory elements associated with the gene. This specific interaction is crucial for understanding the regulation of the KIAA1244 gene and its role in various cellular processes. The modulation of gene expression by these activators can lead to alterations in the gene's activity, providing insights into the gene's function and its contribution to cellular mechanisms.
Chemically, KIAA1244 activators are comprised of sophisticated organic compounds, characterized by their complex structures and diverse functional groups. These groups are strategically arranged to facilitate targeted interactions with the KIAA1244 gene or its regulatory components. The molecular design of these activators is key to their specificity and effectiveness in modulating the gene's activity. The interactions these compounds engage in with the KIAA1244 gene can involve various biochemical processes, such as altering the gene's transcriptional activity, modifying the structure of the DNA, or affecting the function of associated proteins and enzymes. The study of KIAA1244 activators is significant for advancing our understanding of gene regulation and the complex mechanisms that control genetic expression within cells. By investigating the effects of these activators on the KIAA1244 gene, researchers can gain deeper insights into the molecular basis of gene function and regulation. This research contributes to the broader field of molecular biology and genetics, providing valuable knowledge about the intricate processes that govern cellular behavior and the expression of genetic information.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi structure and ARF-related trafficking, potentially impacting ARFGEF3 activity due to its role in vesicular transport processes. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore that alters intracellular ion gradients and may affect ARFGEF3 by disrupting vesicular trafficking and pH homeostasis. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules, potentially affecting ARFGEF3’s role in vesicular transport events that rely on cytoskeletal dynamics. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
As an actin polymerization inhibitor, it may indirectly affect ARFGEF3 activity by modifying the actin cytoskeleton involved in vesicular trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which can modulate numerous signaling pathways, potentially affecting ARFGEF3 expression or activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that could affect ARFGEF3 by altering phosphoinositide signaling involved in membrane trafficking. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Similar to wortmannin, LY294002 is a PI3K inhibitor and may indirectly influence ARFGEF3 through the PI3K-Akt signaling pathway. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
A non-hydrolyzable GTP analogue that could potentially activate ARFGEF3 by stabilizing the GTP-bound form of ARF proteins. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, which can regulate various cellular processes, potentially impacting ARFGEF3 activity indirectly. | ||||||
β-Nicotinamide mononucleotide | 1094-61-7 | sc-212376 sc-212376A sc-212376B sc-212376C sc-212376D | 25 mg 100 mg 1 g 2 g 5 g | $110.00 $150.00 $220.00 $300.00 $600.00 | 4 | |
NMN is a precursor to NAD+, which is involved in cellular metabolism and signaling that might intersect with ARFGEF3-related pathways. | ||||||